FXN and Friedreich ataxia: Treatment with this drug results in STAT1 phosphorylation, nuclear translocation, and initiation of gene transcription of multiple immune-related genes. Upregulates frataxin protein expression in in vitro and in vivo models of FRDA and enhanced motor function in frataxin-deficient mice